Fulcrum Therapeutics, Inc. - 10-Q Filing
Fulcrum Therapeutics reports Q3 financial results including research and development expenses for Losmapimod programs.
Tickers: $FULC
More Regulatory news
- FACT II Acquisition Corp. - 10-Q Filing
- Marblegate Capital Corp - 10-Q Filing
- Greenland Mines Ltd - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- Pinnacle Acquisition Corp - 10-Q Filing
- SUTRO BIOPHARMA, INC. - 8-K Filing
- Aeluma, Inc. - 8-K Filing
- ASTEC INDUSTRIES INC - 8-K Filing
- Live Oak Bancshares, Inc. - 8-K Filing